Summary Tumorigenic mouse lung-derived type 2 cell lines have large reductions in both ,B-adrenergicstimulated cAMP production and ligand binding to ,B-adrenergic receptors. These tumorigenic cells are also relatively insensitive to glucocorticoids. Because glucocorticoids regulate both ,B-adrenergic receptor expression and receptor coupling to the stimulatory guanine nucleotide binding protein G., interactions between the glucocorticoid and P-adrenergic signalling systems were examined. This study demonstrates that ,B-adrenergic ligand binding and agonist sensitivity are increased in a tumorigenic cell line stably expressing a normal glucocorticoid receptor transgene. However, although the transfected tumour cells and non-tumorigenic cells have similar amounts and affinities of ,B-adrenergic agonist and antagonist binding, similar amounts of G, subunits and similar forskolin-stimulated adenylyl cyclase activities, the former remain much less isoproterenol responsive. Competition binding studies demonstrate that tumour cell ,B-adrenergic receptors have both highand low-affinity agonist binding but are functionally uncoupled from G,. This uncoupling may involve an alteration in G,, as guanine nucleotides exhibit a reduced ability to stimulate adenylyl cyclase. Thus, some aspects of tumorigenic cell dysfunction in ,B-adrenergic signalling can be ameliorated by interactions with the glucocorticoid pathway, but additional defects are also involved.
,B-Adrenergic receptor (PAR) expression and P-adrenergic hormone sensitivity increase during lung development and glucocorticoids accelerate these increases (Cheng et al., 1980; Barnes et al., 1984) . In some cell types, glucocorticoids increase PAR expression (Collins et al., 1988) or PAR coupling to G. (Davies and Lefkowitz, 1984) , the heterotrimeric guanine nucleotide-binding protein that regulates PAR stimulation of adenylyl cyclase (Levitzki, 1988) . When compared with two non-tumorigenic mouse lung alveolar type 2-derived cell lines, a number of tumorigenic cell lines of type 2 cell origin exhibit aberrant signal transduction including considerable reductions in sensitivity to both f,-adrenergic (Droms et al., 1989; Lange-Carter et al., 1992) and glucocorticoid (Droms et al., 1993) hormones. As both f,-adrenergic and glucocorticoid signals are major regulators of type 2 cell function (Ballard, 1986) , the defects in these systems may be important aspects of the neoplastic progression of type 2 cells.
The heterotrimeric G protein G, consists of a, ,B and y subunits. Hormone binding to receptor induces G,a to exchange bound GDP for GTP, resulting in adenylyl cyclase activation. Hydrolysis of the terminal phosphate restores the resting state (Levitzki, 1988) . The PAR exhibits two affinity states for agonist binding: one of higher relative affinity (kH) and the other of low affinity (kL) and glucocorticoids can affect both the relative proportions and affinities of these two sites (Davies and Lefkowitz, 1981) . The proposed molecular basis of the high-affinity binding site is that agonist binding to receptor results in formation of a 'ternary complex' consisting of hormone, receptor and G protein (De Lean et al., 1980) . Thus, the existence of high-affinity agonist binding sites is an indicator of the 'coupling' between receptor and G protein. Addition of guanine nucleotides destabilises this ternary complex, resulting in low-affinity hormone binding (Rodbell et al., 1971) . The relative ability of guanine nucleotides to induce the low-affinity state is an indicator of functional coupling between receptor and G-protein Tumour-associated decreases in receptor-coupled adenylyl cyclase activity often result from reduced receptor affinity or number (Hunt and Martin, 1980) . Indeed, the lack of sensitivity of mouse lung tumour cells to P-adrenergic agonists does involve decreased numbers of PAR (LangeCarter et al., 1992) . In addition, these tumour cells exhibited altered guanine nucleotide analogue binding to a 45 kDa membrane associated protein and enhanced cholera toxin responsiveness (Droms et al., 1989; Lange-Carter et al., 1992) , suggesting the hypothesis that G-protein function might be altered in mouse lung tumours. As glucocorticoids enhance both PAR expression and PAR-G. coupling (Davies and Lefkowitz, 1984) , both defects in the ,B-adrenergic signalling pathway could result from the loss of glucocorticoid responsiveness. Glucocorticoids may exert independent effects on the PAR and G. or, as even unoccupied PAR can influence G protein activity (Bond et al., 1995) , the functional alteration in tumour cell G. may result directly from decreased PAR expression. Alternatively, the reduced GTPdependent coupling of receptors to adenylyl cyclase activation observed in hepatomas (Okamura and Terayama, 1976) , suggests that independent defects in G. may 
Materials and methods

Cell lines
The non-tumorigenic (C10) and tumorigenic (A5) type 2 cell lines were derived and cultured as described previously (Bentel et al., 1989; Droms et al., 1989 Droms et al., , 1993 (Cook et al., 1988) . After selection in 600 ,ug ml-1 geneticin (G418, Gibco, Grand Island, NY, USA), a single resistant colony remained. Cells from this colony were isolated and named A5GR1. A5GR1 cells express the transfected glucocorticoid receptor (Droms, 1995) and are routinely cultured with 200 Mg ml-' geneticin to maintain this expression. For all experiments, cells were plated on Corning tissue culture dishes in CMRL 1066 medium with 5% fetal bovine serum (FBS), 100 units ml-' penicillin, and 100 Mg ml-' streptomycin and allowed to attach overnight. On the following day cells were rinsed twice with 0.9% sodium chloride, and media containing 4% FBS from which endogenous steroids were removed with charcoal was added. At this time, 10 nM dexamethasone was added to the samples indicated in Results. Cells were cultured for an additional 4 days before experimental analyses.
Receptor binding studies Cells were plated at a density of 1.3 x 10 -5 x 105 cells per 100 mm culture dish. Membranes were prepared as described previously (Lange-Carter et al., 1992) and stored for up to 9 days at -80°C before use. For saturation binding studies 5-10 Mg of membrane protein per sample was incubated for 90 min at 37°C with (-)'25I-labelled cyanopindolol (125ICYP, 2200 Ci mmol-1; DuPont NEN, Boston, MA, USA) ranging in concentration between 10 and 200 pM as described previously (Lange-Carter et al., 1992) . Protein concentration was determined by the Lowry method (Lowry et al., 1951) . For isoproterenol competition studies, membranes were incubated with 30 pM 125ICYP and isoproterenol ranging in concentrations between 1 nm and 1 mM as described previously (Valverius et al., 1987) . In some cases, GTP was included at the concentrations indicated. Membranes were harvested on glass fibre filters (Whatman GF/C) and counted in a gamma counter. Non-specific binding ranged between 27% and 32% for all conditions and was determined by adding 1 jiM of the unlabelled antagonist propranolol. Nonspecific binding has been subtracted from all data presented. Competition binding data were analysed with the Ligand program (Munson and Rodbard, 1983 (Salomon, 1979) . Some reactions included isoproterenol, guanine nucleotides or forskolin as indicated in Results.
Western blots Equal amounts of membrane protein (40 jig) from dexamethasone-treated ClO and A5GR1 cells were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (Droms et al., 1989) . Resolved determined by saturation binding of the antagonist 1251CYP (Figure 1) . Culturing the A5 cell line with dexamethasone did not increase 1251CYP binding (Figure 1 ). However, when cultured with 10 nM dexamethasone, the A5GR1 cells exhibited similar numbers of,AR as CIO cells (Figure 1 ). (Table I ) and an increased basal adenylyl cyclase activity compared with A5GR1 cells (Table II) . The increased basal adenylyl cyclase activity in CIO cells may be due to a difference in the activity of Gs between cell lines (see below).
CJO and A5GR1 cells have similar forskolin-stimulated adenylyl cyclase activities As both basal and isoproterenol-stimulated adenylyl cyclase activities are lower in ASGR1 than in CIO cells, a difference between cell lines in the activity of adenylyl cyclase is possible. However, when membranes prepared from CIO and ASGR1 cells cultured with dexamethasone were stimulated with 100 gM forskolin, which activates adenylyl cyclase directly (Downs and Aurbach, 1982) , only a slight difference in adenylyl cyclase activity was observed (Figure 2 ). This difference in forskolin-stimulated adenylyl cyclase activity is much less than the isoproterenol sensitivity difference between cell lines. In fact, as the basal activity is also lower in ASGR1 cells, the fold stimulation by forskolin is greater than in CIO membranes. both G,a isoforms, and S49cyc-cells, which do not express G,a (Harris et al., 1985) , are also shown. The blot shown is representative of at least three blots for each subunit.
CIO and A5GRI cells have similar levels of Goc and Gf subunit expression In some cases, the relative levels of expression of G protein subunits can regulate receptor-G protein coupling (Blumer and Thorner, 1990) . Therefore, G,cC and G3 subunit expression were examined on Western immunoblots ( Figure  3 nucleotide. When 8pM GTP was included, CIO had only lowaffinity isoproterenol binding sites. In constrast, even 40/M GTP only minimally reduced isoproterenol affinity in A5GR1 membranes. Membranes were prepared from cells cultured with 10nM dexamethasone and incubated with 30pM 125ICYP and the indicated concentrations of unlabelled isoproterenol. Data were analysed using the Ligand program (Munson and Rodbard, 1983) . Each point is the mean of duplicate determinations from one assay, whereas each line is the best fit from Ligand analysis of the combined data from at least three independent assays, except for A5GR1 -GTP for which two assays were performed (see Table I ). Open symbols, minus GTP; closed symbols, + GTP (8pM for CIO, 40pM for A5GR1). '25ICYP binding in the presence or absence of GTP. In such assays, fl-adrenergic receptors exhibit two affinity states for agonist binding: one of higher affinity (kH) and the other of lower affinity (kL). As demonstrated in Figure 4 and much greater in CIO than in A5GR1 cells in the absence of GTP (Table III) . This high kL is typically observed when flAR-Gs coupling is enhanced by glucocorticoid treatment (Davies and Lefkowitz, 1981) , and is consistent with the increased isoproterenol responsiveness that was observed in CIO cells cultured with dexamethasone (Table I) (Droms et al., 1989; Lange-Carter et al., 1992) , suggesting the hypothesis that G protein function is altered in the mouse lung tumours. A functional alteration in tumour cell Gs could result from the reduced PAR expression rather than from a direct defect in G, itself, as even unoccupied ,BAR can influence G protein activity (Bond et al., 1995) . However, the present study indicates that functional flAR-G, coupling is considerably reduced in A5GR1 cells even when these cells express as many PAR as CIO cells. This lack of functional PAR-G. coupling in A5GR1 cells is indicated by a relative inability of GTP to destablise the high-affinity ternary complex and is associated with decreased effectiveness of guanine nucleotides to activate adenylyl cyclase. As A5GR1 cells exhibit a decrease in non-hydrolysable guanine nucleotide activation of adenylyl cyclase that is independent of glucocorticoid treatment and, consequently, ,BAR expression, an independent defect in tumour cell Gs is implicated.
One potential mechanism of the reduced ability of guanine nucleotides to activate G, in tumorigenic mouse lung-derived cell lines is that guanine nucleotide exchange is reduced (Droms et al., 1989) . The relative inability of GTP to 0 ll 437 destabalise the ternary complex in A5GRl cells is consistent with this hypothesis. Additionally, the difference between CIO and A5GR1 cells in the effectiveness of GTP at activating adenylyl cyclase is even greater than the difference between cell lines when a non-hydrolysable analogue is used. Thus, the GTPase activity of Gs may also be enhanced in the tumour cells. A reduction in the intrinsic guanine nucleotide exchange rate with an increase in the GTPase activity of Gs in tumour cells would be predicted to produce a decrease in basal adenylyl cyclase activity, consistent with the 2-to 3-fold lower basal intracellular cAMP and adenylyl cyclase activity observed in A5 and A5GRl cells compared with CIO cells.
Although a clear role for reduced intracellular cAMP in neoplasia has not been established, agonist-stimulated adenylyl cyclase activity is reduced in many tumours. One possibility is that cAMP interferes with mitogenic signal transduction, as observed in Ratl cells (Cook and McCormick, 1993) and human small-cell lung cancer cells (Viallet et al., 1990) . Reduced activity of the cAMPdependent protein kinase is also a requirement for mitogenesis in some cells (Lamb et al., 1991) . In addition, cAMP inhibits growth in soft agar of mouse lung tumour cell lines (KA Droms, unpublished observation). Tumourassociated reductions in cAMP often result from decreases in the number or affinity of receptors coupled to adenylyl cyclase activation (Hunt and Martin, 1980) . Alternatively, defects in the G-proteins that couple receptors to adenylyl cyclase may also occur. For example, reduced GTPdependent coupling of adrenergic receptors to adenylyl cyclase had been observed in hepatomas (Okamura and Terayama, 1976 
